Venetoclax-based salvage therapy as bridge-to-transplant is feasible and effective in patients with relapsed/refractory AML.

Autor: Unglaub JM; University Hospital Heidelberg, Heidelberg, Germany., Schlenk RF; NCT Trial Center, Heidelberg, Germany., Middeke JM; Uniklinikum Dresden, Dresden, Germany., Krause SW; Uni-Klinikum Erlangen, Erlangen, Germany., Kraus S; Uniklinikum Würzburg, Würzburg, Germany., Einsele H; Universitätsklinikum Würzburg, Würzburg, Germany., Kramer M; AvenCell Europe GmbH, Dresden, Germany., Zukunft S; University Hospital Carl Gustav Carus, Dresden, Germany., Kauer J; University Hospital Heidelberg, Heidelberg, Germany., Renders S; German Cancer Research Center (DKFZ) / University Hospital Heidelberg, Heidelberg, Germany., Katelari E; University Hospital Heidelberg, Heidelberg, Germany., Schliemann C; University Hospital Münster, Münster, Germany., Pabst C; Department of Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany., Luft T; University Hospital Heidelberg, Heidelberg, Germany., Dreger P; University of Heidelberg, Heidelberg, Germany., Röllig C; Department of Internal Medicine I, University Hospital TU Dresden, Dresden, Germany, Dresden, Germany., Bornhäuser M; University Hospital, TU Dresden, Dresden, Germany., Müller-Tidow C; University Hospital Heidelberg, Heidelberg, Germany., Sauer T; University Hospital Heidelberg, Heidelberg, Germany.

Publikováno v: Blood advances [Blood Adv] 2024 Sep 18. Date of Electronic Publication: 2024 Sep 18.

Combinatorial BCL2 Family Expression in Acute Myeloid Leukemia Stem Cells Predicts Clinical Response to Azacitidine/Venetoclax.

Autor: Waclawiczek A; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany., Leppä AM; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany., Renders S; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.; Department of Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany., Stumpf K; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany., Reyneri C; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany., Betz B; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany., Janssen M; Department of Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany., Shahswar R; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Donato E; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany., Karpova D; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri., Thiel V; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany., Unglaub JM; Department of Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany., Grabowski S; Department of Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany., Gryzik S; Department of Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany.; MVZ Hämatologische Diagnostik, Heppenheim, Germany., Vierbaum L; Department of Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany., Schlenk RF; Department of Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; NCT Trial Center, Heidelberg University Hospital and German Cancer Research Center, Heidelberg, Germany., Röllig C; Medizinische Klinik und Poliklinik I, Universitätsklinikum der Technischen Universität Dresden, Dresden, Germany., Hundemer M; Department of Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany.; MVZ Hämatologische Diagnostik, Heppenheim, Germany., Pabst C; Department of Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany., Heuser M; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.; Comprehensive Cancer Center Niedersachsen, Hannover, Germany., Raffel S; Department of Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany., Müller-Tidow C; Department of Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany.; Molecular Medicine Partnership Unit EMBL-UKHD, Heidelberg, Germany.; National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany., Sauer T; Department of Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany., Trumpp A; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.

Publikováno v: Cancer discovery [Cancer Discov] 2023 Jun 02; Vol. 13 (6), pp. 1408-1427.

Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia.

Autor: Rautenberg C; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Medical Faculty, Heinrich Heine-University, Duesseldorf, Germany., Stölzel F; Medizinische Klinik und Poliklinik I, University Hospital Carl Gustav Carus Dresden, Technical University Dresden, Dresden, Germany., Röllig C; Medizinische Klinik und Poliklinik I, University Hospital Carl Gustav Carus Dresden, Technical University Dresden, Dresden, Germany., Stelljes M; Department of Medicine A, University Hospital Münster, Münster, Germany., Gaidzik V; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Lauseker M; Institute for Medical Information Processing, Biometry and Epidemiology, Ludwig-Maximilians-University, Munich, Germany., Kriege O; Department of Medicine III, University Medical Center, Johannes Gutenberg University Mainz, Mainz, Germany., Verbeek M; Department of Medicine III, Technical University of Munich, Munich, Germany., Unglaub JM; Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany., Thol F; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Krause SW; Department V for Internal Medicine, University Hospital Erlangen, Erlangen, Germany., Hänel M; Department of Internal Medicine III, Klinikum Chemnitz, Chemnitz, Germany., Neuerburg C; Department of Oncology, Hematology and Rheumatology, University Hospital Bonn, Bonn, Germany., Vucinic V; Leipzig: Department of Hematology and Cell Therapy, Medical Oncology, Hemostaseology, Leipzig, Germany., Jehn CF; Department of Hematology, Oncology and Stem Cell Transplantation, Asklepios Clinic St. Georg, Hamburg, Germany., Severmann J; Department of Hematology and Stem Cell Transplantation, West German Cancer Center Essen, University Hospital Essen, Essen, Germany., Wass M; Clinic and Policlinic for Internal Medicine IV, University Hospital Halle (Saale), Halle (Saale), Germany., Fransecky L; Departmenf for Internal Medicine II, University Schleswig-Holstein, Kiel, Germany., Chemnitz J; Gemeinschaftsklinikum Mittelrhein GGmbH, Koblenz, Germany., Holtick U; Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany., Schäfer-Eckart K; Department of Internal Medicine V, Oncology and Hematology, Klinikum Nürnberg, Nürnberg, Germany., Schröder J; Clinic for Heaematology and Stem Cell Transplantation HELIOS Clinic Berlin-Buch GmbH, Berlin, Germany., Kraus S; Division of Hematology and Oncology, Department of Internal Medicine II, University of Würzburg, Medical Center, Würzburg, Germany., Krüger W; Clinic and Policlinic for Internal Medicine C, Hematology and Oncology, University of Greifswald, Greifswald, Germany., Kaiser U; Department of Hematology and Oncology, St. Bernward Krankenhaus, Hildesheim, Germany., Scholl S; Department of Internal Medicine II, Hematology and Oncology, University Hospital Jena, Jena, Germany., Koch K; Department of Medicine III, Technical University of Munich, Munich, Germany., Henning L; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Medical Faculty, Heinrich Heine-University, Duesseldorf, Germany., Kobbe G; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Medical Faculty, Heinrich Heine-University, Duesseldorf, Germany., Haas R; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Medical Faculty, Heinrich Heine-University, Duesseldorf, Germany., Alakel N; Medizinische Klinik und Poliklinik I, University Hospital Carl Gustav Carus Dresden, Technical University Dresden, Dresden, Germany., Röhnert MA; Medizinische Klinik und Poliklinik I, University Hospital Carl Gustav Carus Dresden, Technical University Dresden, Dresden, Germany., Sockel K; Medizinische Klinik und Poliklinik I, University Hospital Carl Gustav Carus Dresden, Technical University Dresden, Dresden, Germany., Hanoun M; Department of Hematology and Stem Cell Transplantation, West German Cancer Center Essen, University Hospital Essen, Essen, Germany., Platzbecker U; Leipzig: Department of Hematology and Cell Therapy, Medical Oncology, Hemostaseology, Leipzig, Germany., Holderried TAW; Department of Oncology, Hematology and Rheumatology, University Hospital Bonn, Bonn, Germany., Morgner A; Department of Internal Medicine III, Klinikum Chemnitz, Chemnitz, Germany., Heuser M; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Sauer T; Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany., Götze KS; Department of Medicine III, Technical University of Munich, Munich, Germany., Wagner-Drouet E; Department of Medicine III, University Medical Center, Johannes Gutenberg University Mainz, Mainz, Germany., Döhner K; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Döhner H; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Schliemann C; Department of Medicine A, University Hospital Münster, Münster, Germany., Schetelig J; Medizinische Klinik und Poliklinik I, University Hospital Carl Gustav Carus Dresden, Technical University Dresden, Dresden, Germany., Bornhäuser M; Medizinische Klinik und Poliklinik I, University Hospital Carl Gustav Carus Dresden, Technical University Dresden, Dresden, Germany., Germing U; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Medical Faculty, Heinrich Heine-University, Duesseldorf, Germany., Schroeder T; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Medical Faculty, Heinrich Heine-University, Duesseldorf, Germany. Thomas.schroeder@uk-essen.de.; Department of Hematology and Stem Cell Transplantation, West German Cancer Center Essen, University Hospital Essen, Essen, Germany. Thomas.schroeder@uk-essen.de., Middeke JM; Medizinische Klinik und Poliklinik I, University Hospital Carl Gustav Carus Dresden, Technical University Dresden, Dresden, Germany. Janmoritz.middeke@ukdd.de.

Publikováno v: Blood cancer journal [Blood Cancer J] 2021 Oct 04; Vol. 11 (10), pp. 164. Date of Electronic Publication: 2021 Oct 04.

Effect of dorsal capsular imbrication on intraoperative DRUJ instability following arthroscopic TFCC repair surgery.

Autor: Yeh, Chen-Wei^1,2 (AUTHOR), Hsu, Cheng-En^3,4 (AUTHOR), Ho, Tsung-Yu^1,2 (AUTHOR), Wang, Wei-Chih⁵ (AUTHOR), Lee, Alvin Kai-Xing^1,2 (AUTHOR), Wei, Bor-han⁶ (AUTHOR), Chiu, Yung-Cheng^1,2 (AUTHOR) handchiu@icloud.com

Publikováno v: BMC Musculoskeletal Disorders. 7/15/2024, Vol. 25 Issue 1, p1-11. 11p.

[Defect coverage of fingers and thumb : Indications and treatment].

Autor: Unglaub F; Handchirurgie, Vulpius Klinik, Vulpiusstr. 29, 74906, Bad Rappenau, Deutschland. frank.unglaub@vulpiusklinik.de.; Medizinische Fakultät Mannheim, Universität Heidelberg, Heidelberg, Deutschland. frank.unglaub@vulpiusklinik.de., Langer MF; Unfall‑, Hand- und Wiederherstellungschirurgie, Universitätsklinikum Münster, Münster, Deutschland., Unglaub JM; Handchirurgie, Vulpius Klinik, Vulpiusstr. 29, 74906, Bad Rappenau, Deutschland., Müller LP; Unfall‑, Hand- und Ellenbogenchirurgie, Universitätsklinikum Köln, Köln, Deutschland., Hahn P; Handchirurgie, Vulpius Klinik, Vulpiusstr. 29, 74906, Bad Rappenau, Deutschland., Spies CK; Handchirurgie, Vulpius Klinik, Vulpiusstr. 29, 74906, Bad Rappenau, Deutschland., Löw S; Praxis für Handchirurgie und Unfallchirurgie, Bad Mergentheim, Deutschland.

Publikováno v: Der Unfallchirurg [Unfallchirurg] 2018 Apr; Vol. 121 (4), pp. 321-334.